MedTrace Logo

Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging

NCT02486094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2017-06-12

No results posted yet for this study

Summary

This study tests biopsy and tissue from patients who have been treated for primary rectal cancer at the Royal Marsden Hospital between 2011 and 2013, who have an mrTRG score at post-chemoradiotherapy MRI. It is a retrospective pilot study to determine the apoptotic and proliferative index count pre and post chemoradiotherapy.

Conditions

  • Neoplasms
  • Colorectal Neoplasms
  • Rectal Diseases
  • Gastrointestinal Neoplasms

Sponsors & Collaborators

  • The Royal College of Surgeons of England

    collaborator OTHER

  • Croydon Health Services NHS Trust

    collaborator OTHER

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Gina Brown · Royal Marsden Hospital NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-09-01
Completion
2017-06-07

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02486094 on ClinicalTrials.gov